SELECT ?title WHERE { ?? (rdfs:label|skos:prefLabel|schema:name) ?title . } Pharmakovigilanz

SELECT ?class WHERE { ?? (rdf:type|owl:type) ?class . } DefinedTerm, Term, Validated Entry

SELECT ?description WHERE { ?? (rdfs:comment|schema:description) ?description . } Gesamtheit der Aktivitäten, die sich mit der Aufdeckung, Bewertung, dem Verstehen und der Prävention von Nebenwirkungen oder anderen Arzneimittel-bezogenen Problemen befassen.

Attributes

Name

Pharmakovigilanz

pharmacovigilance

pharmacovigilance

farmacovigilanza

Gesamtheit der Aktivitäten, die sich mit der Aufdeckung, Bewertung, dem Verstehen und der Prävention von Nebenwirkungen oder anderen Arzneimittel-bezogenen Problemen befassen.

Description

Science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

Description

Ensemble des activités consistant à recueillir, à exploiter et à évaluer toute information concernant le risque d’effets indésirables des médicaments.

Description

Insieme delle attività finalizzate all'identificazione, valutazione, comprensione e prevenzione degli effetti indesiderati o di qualsiasi altro problema correlato all'uso dei medicamenti.

dateModified

2022-07-01T12:45:00.8979170Z

Identifier

89737

URL

https://www.termdat.bk.admin.ch/entry/89737

citation

BAG, MM Der Bundesrat will den Zugang zu Arzneimitteln vereinfachen, 2021-09-21 ([Internet, 2021-07-05](https://www.admin.ch/gov/de/start/dokumentation/medienmitteilungen.msg-id-72250.html))

citation

Swissmedic, Human medicines > Market surveillance > Pharmacovigilance ([Internet, 2021-06-15](https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview))

citation

Swissmedic, Médicaments à usage humain > Surveillance du marché > Pharmacovigilance ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/fr/home/medicaments-a-usage-humain/surveillance-du-marche/pharmacovigilance.html))

citation

Swissmedic, Medicamenti per uso umano > Sorveglianza del mercato > Farmacovigilanza ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/it/home/medicamenti-per-uso-umano/sorveglianza-del-mercato/farmacovigilanza.html))

position

Term Note

EXP: in der Schweiz melden medizinische Fachpersonen unerwünschte Arzneimittelwirkungen an Swissmedic

Term Note

EXP: in Switzerland, healthcare professionals report adverse drug reactions to Swissmedic

Term Note

EXP: en Suisse, les professionnels de la santé déclarent les effets indésirables des médicaments à Swissmedic

Term Note

EXP: in Svizzera, gli operatori sanitari notificano le reazioni avverse da medicamenti a Swissmedic

termNoteCitation

nach Swissmedic, Humanarzneimittel > Marktüberwachung > Pharmacovigilance ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/marktueberwachung/pharmacovigilance.html))

termNoteCitation

after Swissmedic, Human medicines > Market surveillance > Pharmacovigilance ([Internet, 2021-06-15](https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview))

termNoteCitation

d'après Swissmedic, Médicaments à usage humain > Surveillance du marché > Pharmacovigilance ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/fr/home/medicaments-a-usage-humain/surveillance-du-marche/pharmacovigilance.html))

termNoteCitation

secondo Swissmedic, Medicamenti per uso umano > Sorveglianza del mercato > Farmacovigilanza ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/it/home/medicamenti-per-uso-umano/sorveglianza-del-mercato/farmacovigilanza.html))

descriptionCitation

nach DE, Paul-Ehrlich-Institut, Pharmakovigilanz (human) ([Internet, 2021-06-15](https://www.pei.de/DE/arzneimittelsicherheit/pharmakovigilanz/pharmakovigilanz-node.html))

descriptionCitation

after European Medicines Agency EMA, Pharmacovigilance: Overview ([Internet, 2021-06-15](https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview))

descriptionCitation

d'après FR, Ministère des solidarités et de la santé, Soins et maladies > Médicaments > La surveillance des médicaments > La pharmacovigilance ([Internet, 2021-06-15](https://solidarites-sante.gouv.fr/soins-et-maladies/medicaments/la-surveillance-des-medicaments/article/la-pharmacovigilance))

descriptionCitation

secondo Agenzia italiana del farmaco AIFA, Sicurezza dei farmaci > Farmacovigilanza ([Internet, 2021-06-15](https://www.aifa.gov.it/farmacovigilanza1))

Outgoing Relationships

property	object
inDefinedTermSet	Health System Terminology
inDefinedTermSet	Swiss Federal Administration
inDefinedTermSet	Terminology of the COVID-19 pandemic
has part	Pharmacovigilance
has part	Arzneimittelüberwachung
Reliability code	Linguistic/formal check completed
termDomain	MEDICINE
termDomain	Pharmacology and toxicology
termDomain	CHEMISTRY

Incoming Relationships: No results found.

Instances of this Class: No results found.

Superclasses of this Class: No results found.

Subclasses of this Class: No results found.

Raw data

{
  "ResourceIRI": "https://register.ld.admin.ch/termdat/89737",
  "QueryResults": {
    "incoming": {
      "Vars": [
        "property",
        "subject"
      ],
      "Bindings": [],
      "Error": ""
    },
    "instances": {
      "Vars": [
        "instance",
        "description"
      ],
      "Bindings": [],
      "Error": ""
    },
    "literals": {
      "Vars": [
        "property",
        "value"
      ],
      "Bindings": [
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/name",
            "Lol": "Name"
          },
          "value": {
            "Type": "literal",
            "Value": "Pharmakovigilanz",
            "Lol": "Pharmakovigilanz"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/name",
            "Lol": "Name"
          },
          "value": {
            "Type": "literal",
            "Value": "pharmacovigilance",
            "Lol": "pharmacovigilance"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/name",
            "Lol": "Name"
          },
          "value": {
            "Type": "literal",
            "Value": "pharmacovigilance",
            "Lol": "pharmacovigilance"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/name",
            "Lol": "Name"
          },
          "value": {
            "Type": "literal",
            "Value": "farmacovigilanza",
            "Lol": "farmacovigilanza"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/description",
            "Lol": "Description"
          },
          "value": {
            "Type": "literal",
            "Value": "Gesamtheit der Aktivitäten, die sich mit der Aufdeckung, Bewertung, dem Verstehen und der Prävention von Nebenwirkungen oder anderen Arzneimittel-bezogenen Problemen befassen.",
            "Lol": "Gesamtheit der Aktivitäten, die sich mit der Aufdeckung, Bewertung, dem Verstehen und der Prävention von Nebenwirkungen oder anderen Arzneimittel-bezogenen Problemen befassen."
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/description",
            "Lol": "Description"
          },
          "value": {
            "Type": "literal",
            "Value": "Science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.",
            "Lol": "Science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem."
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/description",
            "Lol": "Description"
          },
          "value": {
            "Type": "literal",
            "Value": "Ensemble des activités consistant à recueillir, à exploiter et à évaluer toute information concernant le risque d’effets indésirables des médicaments.",
            "Lol": "Ensemble des activités consistant à recueillir, à exploiter et à évaluer toute information concernant le risque d’effets indésirables des médicaments."
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/description",
            "Lol": "Description"
          },
          "value": {
            "Type": "literal",
            "Value": "Insieme delle attività finalizzate all'identificazione, valutazione, comprensione e prevenzione degli effetti indesiderati o di qualsiasi altro problema correlato all'uso dei medicamenti.",
            "Lol": "Insieme delle attività finalizzate all'identificazione, valutazione, comprensione e prevenzione degli effetti indesiderati o di qualsiasi altro problema correlato all'uso dei medicamenti."
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/dateModified",
            "Lol": "dateModified"
          },
          "value": {
            "Type": "literal",
            "Value": "2022-07-01T12:45:00.8979170Z",
            "Lol": "2022-07-01T12:45:00.8979170Z"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/identifier",
            "Lol": "Identifier"
          },
          "value": {
            "Type": "literal",
            "Value": "89737",
            "Lol": "89737"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/URL",
            "Lol": "URL"
          },
          "value": {
            "Type": "literal",
            "Value": "https://www.termdat.bk.admin.ch/entry/89737",
            "Lol": "https://www.termdat.bk.admin.ch/entry/89737"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/citation",
            "Lol": "citation"
          },
          "value": {
            "Type": "literal",
            "Value": "BAG, MM Der Bundesrat will den Zugang zu Arzneimitteln vereinfachen, 2021-09-21 ([Internet, 2021-07-05](https://www.admin.ch/gov/de/start/dokumentation/medienmitteilungen.msg-id-72250.html))",
            "Lol": "BAG, MM Der Bundesrat will den Zugang zu Arzneimitteln vereinfachen, 2021-09-21 ([Internet, 2021-07-05](https://www.admin.ch/gov/de/start/dokumentation/medienmitteilungen.msg-id-72250.html))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/citation",
            "Lol": "citation"
          },
          "value": {
            "Type": "literal",
            "Value": "Swissmedic, Human medicines \u003e Market surveillance \u003e Pharmacovigilance ([Internet, 2021-06-15](https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview))",
            "Lol": "Swissmedic, Human medicines \u003e Market surveillance \u003e Pharmacovigilance ([Internet, 2021-06-15](https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/citation",
            "Lol": "citation"
          },
          "value": {
            "Type": "literal",
            "Value": "Swissmedic, Médicaments à usage humain \u003e Surveillance du marché \u003e Pharmacovigilance ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/fr/home/medicaments-a-usage-humain/surveillance-du-marche/pharmacovigilance.html))",
            "Lol": "Swissmedic, Médicaments à usage humain \u003e Surveillance du marché \u003e Pharmacovigilance ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/fr/home/medicaments-a-usage-humain/surveillance-du-marche/pharmacovigilance.html))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/citation",
            "Lol": "citation"
          },
          "value": {
            "Type": "literal",
            "Value": "Swissmedic, Medicamenti per uso umano \u003e Sorveglianza del mercato \u003e Farmacovigilanza ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/it/home/medicamenti-per-uso-umano/sorveglianza-del-mercato/farmacovigilanza.html))",
            "Lol": "Swissmedic, Medicamenti per uso umano \u003e Sorveglianza del mercato \u003e Farmacovigilanza ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/it/home/medicamenti-per-uso-umano/sorveglianza-del-mercato/farmacovigilanza.html))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/position",
            "Lol": "position"
          },
          "value": {
            "Type": "literal",
            "Value": "1",
            "Lol": "1"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termNote",
            "Lol": "Term Note"
          },
          "value": {
            "Type": "literal",
            "Value": "EXP: in der Schweiz melden medizinische Fachpersonen unerwünschte Arzneimittelwirkungen an Swissmedic",
            "Lol": "EXP: in der Schweiz melden medizinische Fachpersonen unerwünschte Arzneimittelwirkungen an Swissmedic"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termNote",
            "Lol": "Term Note"
          },
          "value": {
            "Type": "literal",
            "Value": "EXP: in Switzerland, healthcare professionals report adverse drug reactions to Swissmedic",
            "Lol": "EXP: in Switzerland, healthcare professionals report adverse drug reactions to Swissmedic"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termNote",
            "Lol": "Term Note"
          },
          "value": {
            "Type": "literal",
            "Value": "EXP: en Suisse, les professionnels de la santé déclarent les effets indésirables des médicaments à Swissmedic",
            "Lol": "EXP: en Suisse, les professionnels de la santé déclarent les effets indésirables des médicaments à Swissmedic"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termNote",
            "Lol": "Term Note"
          },
          "value": {
            "Type": "literal",
            "Value": "EXP: in Svizzera, gli operatori sanitari notificano le reazioni avverse da medicamenti a Swissmedic",
            "Lol": "EXP: in Svizzera, gli operatori sanitari notificano le reazioni avverse da medicamenti a Swissmedic"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termNoteCitation",
            "Lol": "termNoteCitation"
          },
          "value": {
            "Type": "literal",
            "Value": "nach Swissmedic, Humanarzneimittel \u003e Marktüberwachung \u003e Pharmacovigilance ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/marktueberwachung/pharmacovigilance.html))",
            "Lol": "nach Swissmedic, Humanarzneimittel \u003e Marktüberwachung \u003e Pharmacovigilance ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/marktueberwachung/pharmacovigilance.html))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termNoteCitation",
            "Lol": "termNoteCitation"
          },
          "value": {
            "Type": "literal",
            "Value": "after Swissmedic, Human medicines \u003e Market surveillance \u003e Pharmacovigilance ([Internet, 2021-06-15](https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview))",
            "Lol": "after Swissmedic, Human medicines \u003e Market surveillance \u003e Pharmacovigilance ([Internet, 2021-06-15](https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termNoteCitation",
            "Lol": "termNoteCitation"
          },
          "value": {
            "Type": "literal",
            "Value": "d'après Swissmedic, Médicaments à usage humain \u003e Surveillance du marché \u003e Pharmacovigilance ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/fr/home/medicaments-a-usage-humain/surveillance-du-marche/pharmacovigilance.html))",
            "Lol": "d'après Swissmedic, Médicaments à usage humain \u003e Surveillance du marché \u003e Pharmacovigilance ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/fr/home/medicaments-a-usage-humain/surveillance-du-marche/pharmacovigilance.html))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termNoteCitation",
            "Lol": "termNoteCitation"
          },
          "value": {
            "Type": "literal",
            "Value": "secondo Swissmedic, Medicamenti per uso umano \u003e Sorveglianza del mercato \u003e Farmacovigilanza ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/it/home/medicamenti-per-uso-umano/sorveglianza-del-mercato/farmacovigilanza.html))",
            "Lol": "secondo Swissmedic, Medicamenti per uso umano \u003e Sorveglianza del mercato \u003e Farmacovigilanza ([Internet, 2021-06-15](https://www.swissmedic.ch/swissmedic/it/home/medicamenti-per-uso-umano/sorveglianza-del-mercato/farmacovigilanza.html))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/descriptionCitation",
            "Lol": "descriptionCitation"
          },
          "value": {
            "Type": "literal",
            "Value": "nach DE, Paul-Ehrlich-Institut, Pharmakovigilanz (human) ([Internet, 2021-06-15](https://www.pei.de/DE/arzneimittelsicherheit/pharmakovigilanz/pharmakovigilanz-node.html))",
            "Lol": "nach DE, Paul-Ehrlich-Institut, Pharmakovigilanz (human) ([Internet, 2021-06-15](https://www.pei.de/DE/arzneimittelsicherheit/pharmakovigilanz/pharmakovigilanz-node.html))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/descriptionCitation",
            "Lol": "descriptionCitation"
          },
          "value": {
            "Type": "literal",
            "Value": "after European Medicines Agency EMA, Pharmacovigilance: Overview ([Internet, 2021-06-15](https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview))",
            "Lol": "after European Medicines Agency EMA, Pharmacovigilance: Overview ([Internet, 2021-06-15](https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/descriptionCitation",
            "Lol": "descriptionCitation"
          },
          "value": {
            "Type": "literal",
            "Value": "d'après FR, Ministère des solidarités et de la santé, Soins et maladies \u003e Médicaments \u003e La surveillance des médicaments \u003e La pharmacovigilance ([Internet, 2021-06-15](https://solidarites-sante.gouv.fr/soins-et-maladies/medicaments/la-surveillance-des-medicaments/article/la-pharmacovigilance))",
            "Lol": "d'après FR, Ministère des solidarités et de la santé, Soins et maladies \u003e Médicaments \u003e La surveillance des médicaments \u003e La pharmacovigilance ([Internet, 2021-06-15](https://solidarites-sante.gouv.fr/soins-et-maladies/medicaments/la-surveillance-des-medicaments/article/la-pharmacovigilance))"
          }
        },
        {
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/descriptionCitation",
            "Lol": "descriptionCitation"
          },
          "value": {
            "Type": "literal",
            "Value": "secondo Agenzia italiana del farmaco AIFA, Sicurezza dei farmaci \u003e Farmacovigilanza ([Internet, 2021-06-15](https://www.aifa.gov.it/farmacovigilanza1))",
            "Lol": "secondo Agenzia italiana del farmaco AIFA, Sicurezza dei farmaci \u003e Farmacovigilanza ([Internet, 2021-06-15](https://www.aifa.gov.it/farmacovigilanza1))"
          }
        }
      ],
      "Error": ""
    },
    "outgoing": {
      "Vars": [
        "property",
        "object"
      ],
      "Bindings": [
        {
          "object": {
            "Type": "uri",
            "Value": "https://register.ld.admin.ch/termdat/TSS16",
            "Lol": "Health System Terminology"
          },
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/inDefinedTermSet",
            "Lol": "inDefinedTermSet"
          }
        },
        {
          "object": {
            "Type": "uri",
            "Value": "https://register.ld.admin.ch/termdat/terminology-office/ACH",
            "Lol": "Swiss Federal Administration"
          },
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/inDefinedTermSet",
            "Lol": "inDefinedTermSet"
          }
        },
        {
          "object": {
            "Type": "uri",
            "Value": "https://register.ld.admin.ch/termdat/glossary/COVID-19",
            "Lol": "Terminology of the COVID-19 pandemic"
          },
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/inDefinedTermSet",
            "Lol": "inDefinedTermSet"
          }
        },
        {
          "object": {
            "Type": "uri",
            "Value": "https://register.ld.admin.ch/termdat/89737/2/de",
            "Lol": "Pharmacovigilance"
          },
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/hasPart",
            "Lol": "has part"
          }
        },
        {
          "object": {
            "Type": "uri",
            "Value": "https://register.ld.admin.ch/termdat/89737/3/de",
            "Lol": "Arzneimittelüberwachung"
          },
          "property": {
            "Type": "uri",
            "Value": "http://schema.org/hasPart",
            "Lol": "has part"
          }
        },
        {
          "object": {
            "Type": "uri",
            "Value": "https://register.ld.admin.ch/termdat/reliability-code/2",
            "Lol": "Linguistic/formal check completed"
          },
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/reliabilityCode",
            "Lol": "Reliability code"
          }
        },
        {
          "object": {
            "Type": "uri",
            "Value": "https://register.ld.admin.ch/termdat/domain/5",
            "Lol": "MEDICINE"
          },
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termDomain",
            "Lol": "termDomain"
          }
        },
        {
          "object": {
            "Type": "uri",
            "Value": "https://register.ld.admin.ch/termdat/sub-domain/33",
            "Lol": "Pharmacology and toxicology"
          },
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termDomain",
            "Lol": "termDomain"
          }
        },
        {
          "object": {
            "Type": "uri",
            "Value": "https://register.ld.admin.ch/termdat/domain/33",
            "Lol": "CHEMISTRY"
          },
          "property": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/termDomain",
            "Lol": "termDomain"
          }
        }
      ],
      "Error": ""
    },
    "pageClasses": {
      "Vars": [
        "class"
      ],
      "Bindings": [
        {
          "class": {
            "Type": "uri",
            "Value": "http://schema.org/DefinedTerm",
            "Lol": "DefinedTerm"
          }
        },
        {
          "class": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/Term",
            "Lol": "Term"
          }
        },
        {
          "class": {
            "Type": "uri",
            "Value": "https://schema.ld.admin.ch/ValidatedEntry",
            "Lol": "Validated Entry"
          }
        }
      ],
      "Error": ""
    },
    "pageSubtitle": {
      "Vars": [
        "description"
      ],
      "Bindings": [
        {
          "description": {
            "Type": "literal",
            "Value": "Gesamtheit der Aktivitäten, die sich mit der Aufdeckung, Bewertung, dem Verstehen und der Prävention von Nebenwirkungen oder anderen Arzneimittel-bezogenen Problemen befassen.",
            "Lol": "Gesamtheit der Aktivitäten, die sich mit der Aufdeckung, Bewertung, dem Verstehen und der Prävention von Nebenwirkungen oder anderen Arzneimittel-bezogenen Problemen befassen."
          }
        },
        {
          "description": {
            "Type": "literal",
            "Value": "Science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.",
            "Lol": "Science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem."
          }
        },
        {
          "description": {
            "Type": "literal",
            "Value": "Ensemble des activités consistant à recueillir, à exploiter et à évaluer toute information concernant le risque d’effets indésirables des médicaments.",
            "Lol": "Ensemble des activités consistant à recueillir, à exploiter et à évaluer toute information concernant le risque d’effets indésirables des médicaments."
          }
        },
        {
          "description": {
            "Type": "literal",
            "Value": "Insieme delle attività finalizzate all'identificazione, valutazione, comprensione e prevenzione degli effetti indesiderati o di qualsiasi altro problema correlato all'uso dei medicamenti.",
            "Lol": "Insieme delle attività finalizzate all'identificazione, valutazione, comprensione e prevenzione degli effetti indesiderati o di qualsiasi altro problema correlato all'uso dei medicamenti."
          }
        }
      ],
      "Error": ""
    },
    "pageTitle": {
      "Vars": [
        "title"
      ],
      "Bindings": [
        {
          "title": {
            "Type": "literal",
            "Value": "Pharmakovigilanz",
            "Lol": "Pharmakovigilanz"
          }
        },
        {
          "title": {
            "Type": "literal",
            "Value": "pharmacovigilance",
            "Lol": "pharmacovigilance"
          }
        },
        {
          "title": {
            "Type": "literal",
            "Value": "pharmacovigilance",
            "Lol": "pharmacovigilance"
          }
        },
        {
          "title": {
            "Type": "literal",
            "Value": "farmacovigilanza",
            "Lol": "farmacovigilanza"
          }
        }
      ],
      "Error": ""
    },
    "subclasses": {
      "Vars": [
        "subclass",
        "description"
      ],
      "Bindings": [],
      "Error": ""
    },
    "superclasses": {
      "Vars": [
        "superclass",
        "description"
      ],
      "Bindings": [],
      "Error": ""
    }
  }
}

About